Stock Rich List
#4052 on the rich list of 14,644 insiders

Peter Greenleaf

Chief Executive Officer at Aurinia Pharmaceuticals; Director at Pelthos Therapeutics. Based in Durham, North Carolina.

$27.7M
in disclosed stock, −$347K (−1.24%) today
Live prices, last trade 2:54 PM ET
Rank
4052nd of 14,644
Companies held
2
Largest holding
AUPH, 99.4% of total
Latest SEC filing
Oct 2, 2026

What the $27.7M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Aurinia Pharmaceuticals AUPH
Common Stock
Directly1,840,379$14.94$27.5M99.4%Form 4, Mar 2, 2026
Pelthos Therapeutics PTHS
Common Stock
Directly23,087$7.20$166K0.6%Form 4, Oct 2, 2026

Share counts are the amounts Peter Greenleaf reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 2, 2026SoldPTHS797$21.17$17KView
Jul 2, 2026SoldPTHS712$26.00$19KView
Jul 2, 2026SoldPTHS85$27.27$2KView
Apr 2, 2026SoldPTHS420$20.52$9KView
Apr 2, 2026SoldPTHS377$21.36$8KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
4049Robert L. Johnson
Executive Chairman, RLJ Lodging Trust. Bethesda, MD
$27.7M−$515K (−1.82%)
4050Patrick Decker
President & CEO, Xylem. Milwaukee, WI
$27.7M+$2K (+0.01%)
4051Pankaj Ramesh Khanna
Chief Executive Officer, Heidmar Maritime Holdings
$27.7M−$790K (−2.78%)
4052Peter Greenleaf
Chief Executive Officer, Aurinia Pharmaceuticals. Durham, NC
$27.7M−$347K (−1.24%)
4053Martin Migoya
Chairman & CEO, Globant
$27.6M−$1.4M (−4.76%)
4054Doug Jones
Director, President & CMBO, PennyMac Financial Services. Westlake Village, CA
$27.6M−$358K (−1.28%)
4055Assaf Ronen
Chief Platform Officer, Payoneer Global. New York, NY
$27.6M−$229K (−0.82%)

Other Aurinia Pharmaceuticals insiders

All AUPH insiders

Questions

How much stock does Peter Greenleaf own?

Peter Greenleaf holds $27,661,489 in listed stock based on SEC filings and current prices, mostly Aurinia Pharmaceuticals (AUPH). That ranks 4052nd on the Stock Rich List.

Is this Peter Greenleaf's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Peter Greenleaf last buy or sell stock?

The most recent open-market trade on file is a sale of 797 PTHS shares on Oct 2, 2026 at $21.17.